CHICAGO (NewsNation Now) – The US Food and Drug Administration is expected to allow a booster dose of Pfizer-BioNTech’s coronavirus vaccine for children aged 12 to 15 on Monday, The New York Times reported, citing people familiar with the agency’s considerations.
The Times also reports that US regulators plan to allow both teenagers and adults to get an extra dose of Pfizer vaccine five months after receiving a second dose of the vaccine instead of the six-month deadline. as it is now.
A booster shot is also set to be authorized for children aged 5 to 11 years who are immunocompromised.
NewsNation has reached out to the FDA for comment Thursday. The agency responded: “Sorry, we don’t have any information to share.”
Two months after immunizations are approved for children aged 5 to 11, about 14% are fully protected, CDC data shows. This rate is higher among 12 to 17 year olds, almost 53%.
The Centers for Disease Control and Prevention’s vaccine advisory committee is scheduled to meet next week to vote on whether to recommend the changes. If the committee agrees with FDA authorization, Dr. Rochelle P. Walensky, director of the CDC, will endorse the recommendations.
The push for boosters comes as the highly infectious omicron variant continues to spread and childhood COVID-19 hospitalizations are on the rise.
“Almost, not 100%, but close to that, among the very sick children in the hospital with COVID-19 are those whose parents decide they don’t want to vaccinate them. That can be avoided,” Dr. Anthony Fauci told NewsNation.
Facui says that the country’s best protection for children has been shown to be vaccination. He urges parents to “think about the personal safety of their children”.
https://kfor.com/news/fda-reportedly-expected-to-approve-boosters-for-12-to-15-year-olds/ FDA expected to approve boosters for 12 to 15 year olds